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Abstract
Background: Hypertension remains the top global cause of disease burden. Decision support systems (DSS) could
provide an adequate and cost-effective means to improve the management of hypertension at a primary health care
(PHC) level in a developing country, nevertheless evidence on this regard is rather limited.
Methods: Development of DSS software was based on an algorithmic approach for (a) evaluation of a hypertensive
patient, (b) risk stratification (c) drug management and (d) lifestyle interventions, based on Indian guidelines for
hypertension II (2007). The beta testing of DSS software involved a feedback from the end users of the system on
the contents of the user interface. Software validation and piloting was done in field, wherein the virtual
recommendations and advice given by the DSS were compared with two independent experts (government doctors
from the non-participating PHC centers).
Results: The overall percent agreement between the DSS and independent experts among 60 hypertensives on
drug management was 85% (95% CI: 83.61 - 85.25). The kappa statistic for overall agreement for drug management
was 0.659 (95% CI: 0.457 - 0.862) indicating a substantial degree of agreement beyond chance at an alpha fixed at
0.05 with 80% power. Receiver operator curve (ROC) showed a good accuracy for the DSS, wherein, the area under
curve (AUC) was 0.848 (95% CI: 0.741 - 0.948). Sensitivity and specificity of the DSS were 83.33 and 85.71%
respectively when compared with independent experts.
Conclusion: A point of care, pilot tested and validated DSS for management of hypertension has been developed in
a resource constrained low and middle income setting and could contribute to improved management of hypertension
at a primary health care level.
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Introduction
Hypertension exerts a substantial public health burden on
cardiovascular health status and health care systems in India
[1,2]. The pooled prevalence of hypertension is estimated to be
25% (95% CI: 11.66 - 44.8 in males and 13.68 - 44.5 in
females) and 10% (95% CI: 3.7 - 24 in males and 3.69 - 17 in
females) in urban and rural areas of India respectively [3-9]..
By 2025, the rate of hypertension (in %) has been projected to
go up to around 22.9 and 23.6 from the existing rates of 20.6
and 20.9 (in 2000) for Indian males and females respectively
[6]. However, only one fourth of Indian patients on anti-
hypertensives achieve blood pressure control [7]. Recent
studies have shown that physician adherence to evidence
based and standardized medical care results in achieving
adequate blood pressure control among hypertensive patients
[10,11]. Clinical guidelines and algorithms at the point of health
care delivery, in the form of decision making aids to the health
care providers, such as clinical and or computerised decision
support systems (DSS) are a possible way to improve the
standard of care delivery, more so, in a resource constrained
primary health care setting [11,12].
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Clinical and computerised decision support systems have
been developed, validated and field tested in the western world
for management of hypertension during the last decade
[13–15]. Mixed results have been shown for DSS in the
management of hypertension in the developed world for patient
outcomes, but have shown that they may improve the
Physician performance [10-12]. An improvement in the quality
of antihypertensive treatment, concurrently leading to a
considerable reduction in drug costs have been shown for DSS
[16]. There exist no studies in a low and middle income country
(LMIC), wherein, a clinical decision support system, either
computerised or non-computerised, has been shown to aid
clinical decision making and in management of hypertension.
Hence, we performed a study to find out the ease of building
a clinical decision support system, its validity, and to assess
the utility of DSS in managing hypertension at a primary health
care level in a LMIC (India). The primary purpose for
developing the DSS software was to help the end user (health
care providers-physicians serving at the primary health care
level) to (a) undertake a thorough evaluation of risk factors for
hypertension and future cardiovascular diseases (b) to classify
the risk levels for progression to future cardiovascular diseases
(c) to follow a software prompted algorithmic guideline based
drug management (which would be developed based on Indian
Hypertension guidelines II, 2007 [17] and (d) to give alerts on
the counseling on lifestyle changes and adherence to
medication. The aim was to develop, pilot test and validate a
decision support system for hypertensive patients.
Improvement in patient outcomes (reduction in blood pressure
and improvement in BP control rates) and physician skills and
practitioners performance (uptake of evidence based
guidelines for hypertension by the primary care physicians)
were the two main issues that we attempted to address by
developing and deploying a DSS in PHCs.
Methods
The phases of DSS development and validation are
summarized in Figure 1.
Phase I - Development of DSS software
The knowledge base for the evaluation, staging and risk
stratification of a hypertensive patient; algorithmic drug based
management and lifestyle interventions in the DSS were
developed based on the Indian Hypertension II (2007)
guidelines, which have been developed by the Association of
Physicians of India (API) and endorsed by the Cardiological
Society of India, Hypertension Society of India and the API
[17]. Stakeholder and situational analysis formed a major part
of the development exercise. Focus group discussions and
semi structured questionnaires were done with the consenting
34 Primary Health Care (PHC) doctors and nurse assistants in
Figure 1.  Phases of DSS development and validation.  
doi: 10.1371/journal.pone.0079638.g001
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the Mahabubnagar District (least developed district in the state)
Andhra Pradesh State, India (34 out of a total 84.PHC doctors
from the district consented to be a part of the study) during the
months of April - May 2011. Their opinions, on what kind of
clinical support would be required at their resource limited
settings were elicited. Leading questions on feasibility and
operational issues were deliberated at length to find out their
usual practice and management of hypertensive patients
reporting to their PHCs. All of the participants suggested
development of low cost open source health technology
platforms with options for quick scalability and easy
deployment as the primary requirements for the DSS. Written
informed consent was obtained from physicians and nursing
assistants willing to voluntarily undertake testing, implementing
and validating the DSS software. The study protocol was
approved by the Human Biology Ethical Research Committee,
University of Cambridge and the Institutional Ethical Committee
of the Public Health Foundation of India.
Algorithms were developed by the software developers (Data
Template, Bangalore, India) to help build the inferential engine
base of the DSS. Medical language and software coding and
machine language development were done by the medical
software developers (Data Template) using "open source"
platforms (JAVA and MySQL). Figure 2 details the architecture
of the built DSS. Further details are mentioned in File S1.
Caution was taken to ensure that the prepared ‘scenarios’, ‘risk
stratifications’, ‘drug algorithms’ mirrored the Indian
Hypertension II guidelines. The prepared “rules and logic”
sheets [data collection form, drug indications, class of drugs
and dosages, drug algorithms, undesirable combinations, risk
stratification, referral scenarios and lab investigations (where
possible)] were reviewed independently by two physician
experts in the management of hypertension (government
doctors from the non-participating PHC centers).
Phase II - Beta testing of DSS software
The contents of the user interface (UI) were shown to
randomly selected physicians (from a line listed sample frame)
who were working in the PHCs of Mahabubnagar district. The
acceptability and validity of the questionnaire, reasoning for the
questions, suggestions for improvement of data capture from
the drop down menu, inputs on how to structure the summary
page, views on what all the comprehensive elements need to
be stressed in the tailor made recommendations, locally
applicable and relevant life style advices that pop up in the
DSS software upon entry of the data were field tested in 10%
Figure 2.  Architectural diagram for the DSS system.  
doi: 10.1371/journal.pone.0079638.g002
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of physicians (n = 10) from the primary health care centers and
from the community health care centers (n=8). The key
feedback gained from the beta testing phase are summarised
below:
(A) Clinical support required for management of
hypertension.  “Clear definitions of risk and staging of blood
pressure, guidelines on effective lifestyle counseling in local
language, advice on the best drugs from the available ones in
the PHCs, information on the side effects, contraindications
and benefits of each drug class among the antihypertensive
medications, information buttons to cross check the
recommendations and clear cut guidelines on when to refer a
patient to the next level of care” were requested during beta
testing phase
(B): Feasibility.  Almost all the physicians and nurses felt
that this was feasible provided it did not interrupt their daily
workflow patterns. Key elements that were important to them
were the accuracy of the recommendations, contents of the
output, time taken for the input and the speed of the output
from the system. Given the heavy workload of the outpatient
departments in the PHCs, all agreed that a 10 minute window
was the ceiling limit for the time taken between data entry and
output of patient specific recommendations by the DSS.
(C) Operational issues.  “Easily navigable, highly visible
and understandable guidelines” were the main requests from
all the participants. “Maintenance of the knowledge base and
subsequent incorporation of new guidelines as and when they
arose” were also requested.
In addition to the life style counseling on benefits of losing
weight and walking for at least 30 minutes a day; quitting
smoking and avoiding alcohol; and adherence to medications,
end users of the systems specifically requested for
incorporation of locally applicable and relevant life style advices
in the DSS. These included advice on harmful effects of locally
prevalent forms of oral tobacco consumption (a) khaini -
tobacco with slaked lime paste, and areca nuts (b) zarda -
tobacco, lime, spices, vegetable dyes, areca nut (c) pan
masala – betel leaf quid. Along with lifestyle advice to reduce
addition of excess salt to prepared food, end users of the
system also requested to incorporate counseling on reduction
of papads (locally prepared highly salted snacks - seasoned
dough made from lentils, chickpeas, rice, or potato, fried or
cooked with dry heat) and pickles. Most users felt that
figurative explanations for portion sizes for fruit and vegetable
consumption would enable them to counsel better. Hence we
defined portions as follows: A portion can be: vegetables
(fresh, raw, tinned, or frozen) 1 portion = 3 tablespoons; salad,
1 portion = 1 bowl; fresh fruit, 1 portion = 1 medium apple, one
banana; fruit juice (excluding cordials, fruit drinks, squashes), 1
portion = 1 small glass or more.
The time taken for completing the electronic data capture by
the participating physicians was noted (mean time: 10 minutes,
SD: 3 min), so as to achieve a consensus among them that it
doesn’t affect their daily work flow patterns. This critical
feedback from the field on the developed user interface was
relayed to the developers. To understand the field level
difficulties, paucity of the technical resources in a PHC and to
gauge the OPD burden per day per center, visits were
undertaken for a ‘passive observation’ along with the technical
personnel.
Phase III - Validation of DSS in field settings
We retrieved the systems risk staging (screen shot of DSS
showing - Figure 3), tailor made recommendations and the
advice (screenshot of results page - Figure 4) given to the
patient (based on the clinical signs, symptoms and detailed
history notes that the doctor entered in the netbook) from the
field sites during the testing phase and compared them with the
recommendations and advice given by two independent
experts who were distinct from the two government doctors
involved in phase one(experienced physicians from the
government doctors from the non-participating PHC centers).
The information and the reasoning logic displayed on ‘info’
buttons in the DSS output page (screenshot of info page-
Figure 5) was corroborated with the 2007 Indian hypertension
guidelines.
Process and quality assurance
The quality process and the development of DSS software is
summarised in table 1 and explained in detail in File S1.
Testing was included in every iteration to ensure the quality of
deliverables during the DSS development phase. The principal
measure of progress was the delivery of ‘working’ software.
Late changes in requirements were also welcomed as there
was a close and daily cooperation between the business
development people and developers of the DSS application.
Face-to-face conversation (co-location), continuous attention to
technical excellence and good design, simple self – organising
teams with adaptability to changing circumstances were the
key quality assurance norms followed during the DSS
development, beta testing, field testing, pilot testing and finally
during the implementation phase.
Statistical Methods
Sample size: The number of subjects required in a 2-rater
study to detect a statistically significant (p<.05) on a
dichotomous variable, with 80% power, at various proportions
of positive diagnoses, to detect a difference in kappa of 0.40 is
50 for a two tailed test [15]. Assuming a response rate of 80%,
the final sample size was adjusted to 60 Indian hypertensive
patients. The detailed calculations for the overall agreement,
kappa and 95% CI values are mentioned in File S1.
Results
The overall percent agreement (calculated as the sum of all
agreements divided by the total number of observations)
between the DSS software and the independent experts (not
from the study team) on the stage of the blood pressure (BP)
measurement, risk, drug management, side effects and
adverse interactions, lifestyle advice and follow up advice was
90% (95% CI: 88.52 - 90.16); 91.67% (95% CI: 90.16 - 91.80);
85% (95% CI: 83.61 - 85.25); 86.67% (95% CI: 85.25 - 86.89);
90% (95% CI: 88.52 - 90.16); and 83.33% (95% CI: 81.97 -
83.61) respectively (table 2 ). Among 60 hypertensives, the
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PLOS ONE | www.plosone.org 4 November 2013 | Volume 8 | Issue 11 | e79638
decision making of the DSS versus the opinion of the
independent experts (distinct from the two government doctors
involved in phase one) matched for staging of the BP in 54
HTN patients, risk stratification done by the DSS matched the
expert’s opinion in 55 HTN patients, drug management
algorithm suggested by the DSS matched that of the expert in
51 HTN patients. The recommendations suggested for lifestyle
advice, follow up advice and adverse interactions matched in
54, 50 and 52 HTN patients respectively.
Based on the risk category; staging of BP; presence or
absence of associated clinical conditions and target organ
damage; DSS suggested drug management for 39 out of 60
HTN patients, whereas the independent experts opined that 42
out of 60 would need drug management (table 3 and table S1
in File S1). The positive and negative percent agreements were
85.71% and 83.33 % respectively. The overall percent
agreement (Po) between the DSS and expert was 85% (95%
CI: 83.61% - 85.25%). Receiver Operator Curve (ROC)
showed a good accuracy for the DSS, wherein, the area under
curve (AUC) was 0.848 (95% CI: 0.741 - 0.948). Sensitivity and
specificity of the DSS were 83.33 and 85.71% respectively
when compared with independent experts (Figure 6). The
kappa statistic (observed agreement beyond chance divided by
the maximum agreement beyond chance), for overall
agreement for drug management was 0.659 (95% CI: 0.457 -
0.862) indicating a substantial degree of agreement beyond
chance at an alpha fixed at 0.05 with 80% power. The
prevalence index was 0.31 and the bias index (extent to which
the raters disagree on the proportion of positive or negative
cases) was 0.05.
Discussion
We built a clinical decision support system, based on 2007
Indian hypertension II guidelines, for staging and risk
stratification of hypertension, for suggesting evidence based
recommendations on drug management and life style advice of
hypertensive patients to better manage hypertensive patients
at a primary healthcare level. We report a good accuracy of our
built DSS, with an AUC of 0.848 (95% CI: 0.74-0.94) with
sensitivity and specificity values of 0.83 and 0.85 respectively.
A moderate to substantial agreement of 0.66 (estimate for
kappa) on drug management of hypertensive patients was
noticed between the DSS and an independent expert after
adjusting for occurrence of a chance agreement. The 95% CI
for kappa fell in the fair to substantial agreement range (0.43 to
0.89). 31% of agreements on the positive classification differed
from that of the negative classification and the disagreement
between the DSS (virtual) and the independent expert (real) on
the proportion of positive or negative cases was 5%. The
prevalence and bias index, the 95% CI for kappa and positive
and negative agreements of 0.91 and 0.73 indicate the
robustness of the yielded kappa.
Comparison with previous literature
One of the first specific DSS built for managing hypertension,
the ATHENA-Hypertension (Assessment and Treatment of
Hypertension: Evidence-based Automation built by Stanford
Medical Informatics) system [13], a similar knowledge-based
DSS like our built DSS, showed that implementation and
deployment of clinical decision support was feasible in large
clinical settings [14]. Differences in ATHENA system and DSS
in drug management, prescription of antihypertensives,
availability of physiological testing and risk classification are
explained in detail in the File S1. The clinical data
visualizations and evidence to support specific
recommendations in ATHENA were more comprehensive than
the physician in adding, substituting or increasing drug therapy,
where the criteria were clear in the pre-defined rules [13,15].
Our study showed a moderate to substantial agreement on
Figure 3.  DSS screenshot showing “rules” and DSS engine logic based on 2007 Indian Hypertension II guidelines for
risk staging.  
doi: 10.1371/journal.pone.0079638.g003
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drug management of hypertensive patients between DSS and
the independent physician evaluators. Care was taken to
ensure that testing data came from real patients and
representative physician evaluators who were familiar with the
clinical settings similar to the offline ATHENA system testing
study (a ‘physician-evaluator who was a representative of the
end-user population’ validated the system) [15].
The concordance rates for definite indication and absolute
contraindication for drug management in hypertension were
85% and 100%, respectively when the knowledge base for a
hypertension management DSS (LIGHT) was verified and
validated [18]. We report similar findings from our study, i.e.,
positive and negative percent agreements were 85.71% and
83.33 % respectively and the overall percent agreement (Po)
between the DSS and experts was 85% (95% CI: 83.61% -
85.25%). In an on-demand DSS study for primary care
management of hypertension (similar clinical settings of
primary health care in our study), physicians were more willing
to use DSS in complex clinical situations, when the reasoning
logic was clearly demarcated [19]. Our DSS has display
buttons for information on the logic and engine rules that help
in arriving at decisions based on patient profile and clinical
history.
A recent paper on ‘Analysis on the accuracy of a decision
support system for hypertension monitoring’ on a developed
DSS – the WeHealth system [20], proposed a theoretical
method to evaluate the accuracy of WeHealth hypertension
monitoring system by linking the system accuracy with the
distribution of sensors’ errors (systolic and diastolic BP) and
the errors of context (entry risk factors, target organ damage
and complications). The difference in accuracy was less than
1% when traditional (physician review) was compared with the
WeHealth DSS [20]. The difference in accuracy between our
DSS and the independent experts was in between 2-4% (table
S2 in File S1). Moreover the value of AUC of 0.848 with a tight
range of 95% CI (0.74-0.94) suggests a good accuracy of our
DSS.
Strengths
Our DSS has user friendly and properly structured
(recommendation and reasoning info buttons) pull-down lists; a
consistent use of information or use of symbols and color for
Figure 4.  DSS screenshot showing staging of hypertension, risk category, and tailor made recommendations for drug
treatment, pharmacological indication and contraindications, lifestyle support and follow up advice.  
doi: 10.1371/journal.pone.0079638.g004
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improving visibility and speed of navigation; a clinical user
interface that mimics their paper predecessors; and has a
standardized evidence based risk stratification, staging of BP,
guidelines and recommendations for drug, lifestyle and follow
up advice for Indian patients suffering from hypertension. The
decision algorithm is also visible as a pop up menu for the
clinicians to see and find out the logic behind the decision.
Moreover, we have taken into confidence and involved the end
users of the DSS (clinicians and treating physicians at a
primary health care level) at every stage of the development,
pilot testing and validations so that a consistent understanding
of the purpose of the DSS system and the functionality of the
user interface takes place during the implementation phase.
Incomplete or inaccurate data entry has been prevented as the
ceiling (maximum and minimum permissible values) limits for
each variable have been defined during the coding process. A
summary sheet highlighting the patient specific key risk factors,
stage of BP, any co-morbid conditions is in place, so that the
cognitive burden of absorbing the information does not prevent
the end users from thinking about what the information means.
 We have validated the DSS by attempting to simulate a real
life scenario by bringing in independent evaluators who were
Figure 5.  DSS screenshot showing the “rules” and DSS engine logic based on 2007 Indian Hypertension II guidelines for
drug management.  
doi: 10.1371/journal.pone.0079638.g005
Table 1. Development process for the DSS software.
Units Activities
Unit I Detailed system analysis; technology evaluation, design documentation and user interface (UI) design; algorithm development; creation of login/logout, doctor andlocation details; security feature implementation; and phase release for testing
Unit II Patient registration, patient's consequent visit details entry, and development of algorithms for consequent visit with comparison
Unit III Conversion to PDF of the user details; UI for the advice with print support; synchronization option with the centralized database (DB); version checking and updateof patient data; alerts and message prompting; scheduler for DB backup; installer for the application; and phase release for quality audits (QA) and production
Unit IV Installation Guide; user guide and user acceptance testing (UAT)
doi: 10.1371/journal.pone.0079638.t001
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not otherwise involved in the DSS project, but were a part of
the government run primary health care system care givers.
The SAGE (Standards-Based Sharable Active Guideline
Environment) consortium project recommends that a DSS
should have “a complex clinical guideline as a series of
recommendation sets” [21]. Our DSS takes into account the
context, decision, action and route to create a standards-based
decision support’s system. We followed the SAGE guidelines
model which suggests that DSS (a) must be delivered through
features available within the existing clinical information
systems (b) must facilitate clinical workflow non-intrusively and
(c) must be efficient and allow easy inspection of the underlying
clinical logic [22]. The fundamental principle involved in
evaluating methods in medical informatics is to do a
comprehensive evaluation of the consistency, depth and
coverage of the knowledge encoded in the system [23]. Each
of these areas was tested in our DSS validation. Finally,
implementation of clinical guidelines through the DSS acts as a
teaching tool for the treating physicians and also ensures
adherence to current guidelines resulting in quality of health
care services provided.
Miller et al [24] underlined the importance of thinking through
the necessary key features during the process of developing a
medical diagnostic and treatment algorithm. The validation for
the system performance was based on what clinical
practitioners would use or require during actual practice. The
boundaries and limitations of the knowledge-base and
available system functions have been specified upfront.
Particular emphasis was paid to address the system-related
(unambiguous and easy navigability of end user interface),
user-related (lack of training with the system, failure to
understand key system functions, lack of medical knowledge,
etc.), and external variables (lack of available gold standards,
quality of independent reviewers) influences on the validation
process.
Limitations
Developing a standard for comparing the DSS
recommendations turned out to be a challenge. Although,
physician reviews have traditionally served as the gold
standard, errors owing to the large and voluminous data
analysis (60 patients’ history and physical findings) may have
limited the validity. Similarly, the authors of ATHENA-DSS
study also acknowledge that an evolved consensus between
the physician review and recommendations put forth by the
system could turn out to be a better gold standard [15]. In the
CHAID (Chi-squared Automatic Interaction Detection) DSS for
hypertension management built by using a data mining
approach, clustering and the association rules were used for
validating decisions made in hypertension management [25].










treatment 36 (a) 3 (b)
DSS did not suggest drug
treatment 6 (c) 15 (d)
doi: 10.1371/journal.pone.0079638.t003
Figure 6.  Receiver Operator Curve for comparing the
DSS and independent experts on drug management.  
doi: 10.1371/journal.pone.0079638.g006
Table 2. Percent agreement, lower and upper bounds for attributes between DSS and independent expert.
Attribute m n v1 v2 u v3 v4 w % agreement LB % UB%
Stage of BP 54 60 108 14 2.56 110 12 0.48 90.00 88.52 90.16
Risk category 55 60 110 12 2.79 112 10 0.46 91.67 90.16 91.80
Drug management 51 60 102 20 2.39 108 14 0.50 85.00 83.61 85.25
Life style advice 54 60 108 14 2.56 110 12 0.48 90.00 88.52 90.16
Follow up advice 50 60 100 22 2.09 102 20 0.54 83.33 81.97 83.61
Adverse event 52 60 104 18 2.27 106 16 0.52 86.67 85.25 86.89
m = number of observations where DSS and expert agreed; n = total number of observations; v1 = 2*m; v2 = 2*(n - m + 1); u = the 2.5th percentile of the F distribution with
v1 and v2 degrees of freedom; v3 = 2*(m+1); v4 = 2*(n-m); w = 97.5th percentile of the F distribution with v3 and v4 degrees of freedom; % agreement = (total number of
agreements/total sample size); LB% = lower bound of confidence interval in percentage; UB% = upper bound of confidence interval in percentage
doi: 10.1371/journal.pone.0079638.t002
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More specifically, data warehouse architecture was used to
collect and integrate relevant data from hospital clinical
information systems. Our study, being a pilot study to test out
the feasibility of converting clinical practise guidelines into
implementable and hands on decision rules doesn’t integrate
all the data from patient electronic records and hospital clinical
information systems as the infrastructure for health
management information system is still at a nascent stage in
India.
The knowledge based engine in our system, built mostly on
“if and then” scenarios limits itself to management of
hypertension only at primary care settings. Similarly, potential
interactions with other drugs that would have had an effect on
blood pressure have not been built in the system. Referral
scenarios are suggested when the reasoning engine is
confronted with complex data that can be managed only at
secondary and tertiary care settings. However, since the issue
of random agreement purely by chance has been adequately
addressed, we believe that our finding of moderate to
substantial agreement between the virtual (DSS) and the real
(physicians review) are valid (since we report the AUC and the
95% CI for AUC in the ROC curve, 95% CI for kappa,
prevalence and bias index).
DSS used in the developed world for management of
hypertension have shown success if the DSS seamlessly
blends in the daily work patterns of the end users, without
burdening them on the cognitive or time scales, and improves
their work efficiency. The time spent on manual data entry, loss
of opportunity for decision, and the onus or responsibility in the
event of an error are major areas that need to be addressed in
future DSS studies. We have followed a systematic approach
for DSS validation study wherein, feasibility, reliability in
performance, DSS components’ testing, evaluation of DSS in
the context in which they were developed were initially done
before a randomised control trial was planned. The results of
the just completed randomised trial [26] will help us to
undertake a formal evaluation of DSS on patient specific
outcomes.
Conclusion
A point of care, pilot tested and validated virtual DSS which
matches the real life scenario for management of hypertension
has been developed for improved management of hypertension
at a primary health care level in a low and middle income
setting. Public health policy decision makers could use the
innovative DSS platform for (a) delivering evidence based non
communicable disease (NCD) health care delivery models
(promotion, prevention and treatment), (b) improving health
system efficiency, and (c) reducing health disparities in primary
care settings in low and middle income (LMICs) countries.
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